• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

RETRACTED ARTICLE: Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts.

作者信息

Huang Jing, Li Zhou, Fu Lijun, Lin Dahe, Wang Chunhua, Wang Xiumei, Zhang Lifen

机构信息

Fujian Provincial Key Laboratory of Ecology-Toxicological Effects and Control for Emerging Contaminants, Key Laboratory of Ecological Environment and Information Atlas (Putian University) Fujian Provincial University, Key Laboratory of Loquat Germplasm Innovation and Utilization (Putian University), Fujian Province University, College of Environmental and Biological Engineering, Putian University, Putian, 351100, Fujian, China.

School of Public Health, Southern Medical University, Guangzhou, 510515, Guangdong, China.

出版信息

J Cancer Res Clin Oncol. 2021 Jun;147(6):1745. doi: 10.1007/s00432-020-03299-3. Epub 2020 Jul 2.

DOI:10.1007/s00432-020-03299-3
PMID:32617702
Abstract
摘要

相似文献

1
RETRACTED ARTICLE: Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts.撤回文章：基于三个独立队列对透明细胞肾细胞癌肿瘤突变负荷的综合表征
J Cancer Res Clin Oncol. 2021 Jun;147(6):1745. doi: 10.1007/s00432-020-03299-3. Epub 2020 Jul 2.
2
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.基于生物信息学和实验验证的透明细胞肾细胞癌中铜死亡特征的构建。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17451-17466. doi: 10.1007/s00432-023-05259-z. Epub 2023 Oct 27.
3
Multi-omics analysis reveals the role of ribosome biogenesis in malignant clear cell renal cell carcinoma and the development of a machine learning-based prognostic model.多组学分析揭示核糖体生物合成在恶性透明细胞肾细胞癌中的作用以及基于机器学习的预后模型的开发。
Front Immunol. 2025 Jun 26;16:1602898. doi: 10.3389/fimmu.2025.1602898. eCollection 2025.
4
Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategies.非透明细胞肾细胞癌的最新进展：生物学与治疗策略
Ther Adv Med Oncol. 2025 Jun 16;17:17588359251345722. doi: 10.1177/17588359251345722. eCollection 2025.
5
NME4: A novel metabolic-associated biomarker for prognosis prediction and immunotherapy response evaluation in clear cell renal cell carcinoma.NME4：一种用于透明细胞肾细胞癌预后预测和免疫治疗反应评估的新型代谢相关生物标志物。
Mol Immunol. 2025 Aug;184:149-163. doi: 10.1016/j.molimm.2025.06.011. Epub 2025 Jul 1.
6
N6-methyladenosine long non-coding RNAs reveal novel tool to implicate overall survival and immune microenvironment in renal clear cell carcinoma.N6-甲基腺苷长非编码 RNA 揭示了一种新的工具，可提示肾透明细胞癌的总体生存率和免疫微环境。
J Cancer Res Clin Oncol. 2023 Jul;149(8):4675-4687. doi: 10.1007/s00432-022-04389-0. Epub 2022 Oct 7.
7
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma.解读线粒体自噬相关特征在透明细胞肾细胞癌临床结局和微环境异质性中的意义。
J Cancer Res Clin Oncol. 2023 Nov;149(17):16015-16030. doi: 10.1007/s00432-023-05349-y. Epub 2023 Sep 9.
8
Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: an integrative analysis across multiple tumor types.胰高血糖素样肽-1受体（GLP1R）表达对癌症生存的预后影响及其对GLP-1R激动剂治疗的意义：一项跨多种肿瘤类型的综合分析
Geroscience. 2025 Jan 8. doi: 10.1007/s11357-024-01494-5.
9
A predictive model for WHO/ISUP pathologic grading of renal clear cell carcinoma based on CT radiomics: a multicenter study.基于CT影像组学的肾透明细胞癌WHO/ISUP病理分级预测模型：一项多中心研究
BMC Nephrol. 2025 Jul 1;26(1):296. doi: 10.1186/s12882-025-04268-z.
10
Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.透明细胞肾细胞癌的基因组学：系统评价和荟萃分析。
Eur Urol. 2022 Apr;81(4):349-361. doi: 10.1016/j.eururo.2021.12.010. Epub 2022 Jan 3.

引用本文的文献

1
Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy.肾透明细胞癌中与肿瘤微环境相关的分子异质性特征分析以辅助免疫治疗
Front Cell Dev Biol. 2021 Sep 23;9:736540. doi: 10.3389/fcell.2021.736540. eCollection 2021.
2
Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy Multi-Omics Analysis.透明细胞肾细胞癌中缺氧相关分子亚型的特征分析以辅助免疫治疗和靶向治疗：多组学分析
Front Mol Biosci. 2021 Jun 25;8:684050. doi: 10.3389/fmolb.2021.684050. eCollection 2021.
3
Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma.
预测转移性肾细胞癌对免疫疗法的反应
Cancers (Basel). 2020 Sep 18;12(9):2662. doi: 10.3390/cancers12092662.